October 2018 FDA Recall Drug by H J Harkins Company Inc Dba Pharma Pac
D-0415-2019 - Presence of Particulate Matter
This Class II drug recall was voluntarily initiated by H J Harkins Company Inc Dba Pharma Pac on October 18, 2018 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0415-2019
Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing.
10-18-2018
02-06-2019
84, 5 ml bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
H J Harkins Company Inc dba Pharma Pac
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the USA and Puerto Rico
05-06-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
GENTAMICIN OPTH-SOL 5ml Compare: Garamycin. 5-mL plastic dropper bottle, Mfg: AKORN 17478-0283-10. NDC 52959-0103-00
Batch or Lot Expiration Information
Lot# GNT01AK, Exp. 02/19 & GNT07AK, Exp. 3/20